Loading...
Portfolio Diversification
Range
Most Diversified
25 instruments
January 9, 2026
Least Diversified
0 instruments
October 20, 2025
Average
18.7 instruments
Most Consistent Holdings
Top 5
BDX99.5%
DXCM99.5%
MRK99.43%
NVO99.43%
TNDM99.37%
Position Sizing
Analysis
Market Exposure
Analysis
Top Sectors
Top 5
Top Countries
Top 5
Holdings over time
(Since January 1, 2022)
| Instrument | Avg. Exposure | Current Exposure | Time Holding | Last Closed |
|---|---|---|---|---|
 Eli Lilly (LLY) | 11.07% | 5.89% | 98.99% | - |
| Merck (MRK) | 8.64% | 5.42% | 99.43% | - |
| Novo-Nordisk (NVO) | 8.29% | 2.99% | 99.43% | - |
 Abbott (ABT.US) | 5.91% | 2.9% | 99.24% | - |
 AstraZeneca (AZN.L) | 5.8% | 0% | 90.22% | 1/7/2026 |
| DexCom (DXCM) | 5.41% | 6.19% | 99.5% | - |
 Medtronic (MDT.US) | 4.79% | 3.64% | 99.31% | - |
 Insulet (PODD) | 4.27% | 2.36% | 99.37% | - |
 Johnson & Johnson (JNJ) | 3.95% | 4.87% | 73.19% | - |
| BD (BDX) | 3.55% | 2.45% | 99.5% | - |
 Roche (ROP.ZU) | 3.51% | 0% | 90.22% | 1/7/2026 |
 Sanofi (SAN.PA) | 3.51% | 0% | 90.09% | 1/7/2026 |
 Bristol-Myers Squibb (BMY) | 2.96% | 4.16% | 66.31% | - |
| Tandem Diabetes (TNDM) | 2.81% | 2.8% | 99.37% | - |
 Neurocrine Biosciences (NBIX) | 2.75% | 5.61% | 54.7% | - |
 Ascendis Pharma (ASND) | 2.74% | 4.19% | 54.89% | - |
 Alkermes (ALKS) | 2.46% | 5.73% | 54.45% | - |
 Halozyme (HALO) | 2.44% | 3.51% | 53% | - |
 MannKind (MNKD) | 2.25% | 2.22% | 68.9% | - |
 Bayer (BAYN.DE) | 2.25% | 0% | 44.35% | 1/3/2024 |
 Pfizer (PFE) | 1.56% | 5.29% | 31.55% | - |
 Rhythm Pharmaceuticals (RYTM) | 1.55% | 3.62% | 32.43% | - |
 Almirall (ALM.MC) | 1% | 0% | 44.35% | 1/3/2024 |
 GlaxoSmithKline (GSK) | 0.96% | 0% | 23.22% | 1/8/2025 |
 Sandoz (SDZNY) | 0.58% | 0% | 13.19% | 8/1/2024 |
 GSK (GSK.L) | 0.43% | 0% | 11.17% | 1/3/2024 |
 Viking Therapeutics (VKTX) | 0.43% | 4.13% | 9.09% | - |
 Amgen (AMGN) | 0.42% | 4.53% | 9.27% | - |
 Vertex (VRTX) | 0.4% | 4.27% | 9.15% | - |
 West Pharma (WST) | 0.38% | 4.91% | 9.09% | - |
 AstraZeneca (AZN) | 0.34% | 3.6% | 9.21% | - |
 Hansoh Pharmaceutical Group (3692.HK) | 0.28% | 2.48% | 9.09% | - |
 Lexicon Pharmaceuticals (LXRX) | 0.24% | 0% | 11.23% | 1/3/2024 |
 Beta Bionics Inc (BBNX) | 0.14% | 1.66% | 9.21% | - |
Exposure over time
Exposure by Sector
Exposure by Country
Portfolio Time Machine
Portfolio date
01
01
2026
| Instrument | Invested | Value |
|---|---|---|
| Eli Lilly (LLY) | 4.38% | 10.2% |
| Johnson & Johnson (JNJ) | 5.69% | 6.79% |
| Merck (MRK) | 6.25% | 6.78% |
| Ascendis Pharma (ASND) | 3.82% | 5.98% |
| AstraZeneca (AZN.L) | 4.54% | 5.71% |
| Insulet (PODD) | 4.37% | 5.34% |
| DexCom (DXCM) | 8.7% | 5.3% |
| Neurocrine Biosciences (NBIX) | 5.34% | 5.27% |
| Medtronic (MDT.US) | 5.6% | 5.03% |
| Halozyme (HALO) | 4.23% | 4.78% |
| Roche (ROP.ZU) | 5% | 4.53% |
| Abbott (ABT.US) | 4.59% | 4.49% |
| Pfizer (PFE) | 5.13% | 4.42% |
| Bristol-Myers Squibb (BMY) | 5.1% | 4.01% |
| Alkermes (ALKS) | 4.26% | 3.77% |
| BD (BDX) | 5.12% | 3.61% |
| MannKind (MNKD) | 4.12% | 3.44% |
| Sanofi (SAN.PA) | 3.96% | 3.01% |
| Tandem Diabetes (TNDM) | 3.54% | 2.66% |
| Novo-Nordisk (NVO) | 3.88% | 2.63% |
Cash & Instruments Over Time
Unlock Premium Features
Get access to this feature and many more with BullAware Pro.